Type 1 diabetes is particularly a serious disease and its management has been a journey fraught with various challenges. But MIT engineering announces a revolution in the treatment of diabetes which can be potentially transformative. This innovation is an implantable device, containing not only insulin-producing cells but also its own oxygen production factory. It is incredible that this device is capable of producing oxygen by splitting the user’s vapor. This is a phenomenal feat, with its posi

MIT engineers have developed an implantable device for Type 1 diabetes treatment. The device contains insulin-producing cells and self-generates oxygen by splitting bodily water vapor. Promising results in diabetic mice show stabilized glucose levels. This advancement could eliminate daily insulin injections, offering a groundbreaking solution for diabetes management.

    • Cocodapuf@lemmy.world
      2·
      1 year ago

      So many questions…

      Is the “Oxygen factory” component worn externally?

      How exactly does it separate the Oxygen from vapor? What do they mean by “vapor”, does that mean the implant needs access to the respiratory system somehow?